⌘K

Home/Filings/4/0001213900-22-016988

4//SEC Filing

Bassan Merav 4

Accession 0001213900-22-016988

CIK 0001739174other

View on SEC.gov Company Profile

Filed

Mar 30, 8:00 PM ET

Accepted

Mar 31, 5:31 PM ET

Size

5.5 KB

Accession

0001213900-22-016988

Insider Transaction Report

Form 4

Period: 2022-03-29

Chief Development Officer

Transactions

Award
Common Stock Options - Right to Buy
2022-03-29+100,000→ 100,000 total
Exercise: $1.41Exp: 2032-03-29→ Common Stock (100,000 underlying)

Footnotes (1)

[F1]The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 29, 2023, and the remainder vesting in 12 equal quarterly installments over three years.

Documents

1 file

4
ownership.xmlPrimary

Issuer

BiomX Inc.

CIK 0001739174

Entity typeother

Related Parties

1

filerCIK 0001792702

Filing Metadata

Form type: 4
Filed: Mar 30, 8:00 PM ET
Accepted: Mar 31, 5:31 PM ET
Size: 5.5 KB

View on SEC.gov